Comerica Bank Cytokinetics Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Cytokinetics Inc stock. As of the latest transaction made, Comerica Bank holds 237,022 shares of CYTK stock, worth $11.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

237,022

Previous 166,180 42.63%

Holding current value

$11.2 Million

Previous $9 Million 39.0%

% of portfolio

0.05%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $3.63 Million - $4.26 Million	70,842 Added 42.63%	237,022 $12.5 Million
Q2 2024 Aug 15, 2024	BUY	$47.86 - $75.05 $1.69 Million - $2.65 Million	35,374 Added 27.04%	166,180 $9 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $5.42 Million - $9.18 Million	84,967 Added 185.36%	130,806 $9.17 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $25,267 - $78,480	940 Added 2.09%	45,839 $3.83 Million
Q3 2023 Nov 21, 2023	BUY	$29.46 - $36.61 $1.32 Million - $1.64 Million	44,899 New	44,899 $1.32 Million
Q4 2022 Jan 26, 2023	SELL	$35.77 - $51.11 $569,994 - $814,437	-15,935 Reduced 22.12%	56,094 $0
Q3 2022 Oct 28, 2022	SELL	$38.54 - $54.52 $36,805 - $52,066	-955 Reduced 1.31%	72,029 $3.25 Million
Q2 2022 Aug 02, 2022	BUY	$33.93 - $48.92 $76,919 - $110,901	2,267 Added 3.21%	72,984 $2.92 Million
Q1 2022 Apr 27, 2022	BUY	$29.74 - $46.0 $26,914 - $41,630	905 Added 1.3%	70,717 $2.6 Million
Q4 2021 Feb 18, 2022	SELL	$34.35 - $46.38 $197,272 - $266,360	-5,743 Reduced 7.6%	69,812 $3.18 Million
Q3 2021 Nov 22, 2021	BUY	$18.54 - $35.74 $160,278 - $308,972	8,645 Added 12.92%	75,555 $2.7 Million
Q2 2021 Aug 26, 2021	SELL	$19.79 - $26.99 $93,408 - $127,392	-4,720 Reduced 6.59%	66,910 $1.32 Million
Q1 2021 Apr 28, 2021	SELL	$18.57 - $25.68 $44,066 - $60,938	-2,373 Reduced 3.21%	71,630 $1.67 Million
Q4 2020 Jan 28, 2021	BUY	$15.26 - $28.61 $7,248 - $13,589	475 Added 0.65%	74,003 $1.54 Million
Q3 2020 Oct 30, 2020	BUY	$20.58 - $28.96 $222,963 - $313,752	10,834 Added 17.28%	73,528 $1.59 Million
Q2 2020 Jul 31, 2020	BUY	$11.15 - $24.64 $61,001 - $134,805	5,471 Added 9.56%	62,694 $1.48 Million
Q1 2020 May 01, 2020	BUY	$8.75 - $16.3 $18,891 - $35,191	2,159 Added 3.92%	57,223 $674,000
Q4 2019 Feb 07, 2020	BUY	$7.95 - $11.84 $2,345 - $3,492	295 Added 0.54%	55,064 $584,000
Q3 2019 Oct 31, 2019	BUY	$10.82 - $14.25 $10,214 - $13,452	944 Added 1.75%	54,769 $623,000
Q2 2019 Aug 02, 2019	SELL	$7.95 - $11.25 $2,615 - $3,701	-329 Reduced 0.61%	53,825 $0
Q1 2019 May 02, 2019	BUY	$5.95 - $10.19 $10,757 - $18,423	1,808 Added 3.45%	54,154 $0
Q4 2018 Feb 06, 2019	SELL	$5.91 - $9.29 $1,347 - $2,118	-228 Reduced 0.43%	52,346 $357,000
Q3 2018 Nov 01, 2018	SELL	$6.4 - $9.85 $3,334 - $5,131	-521 Reduced 0.98%	52,574 $380,000
Q2 2018 Aug 01, 2018	BUY	$6.9 - $9.9 $4,202 - $6,029	609 Added 1.16%	53,095 $467,000
Q1 2018 May 01, 2018	BUY	$7.2 - $10.05 $7,185 - $10,029	998 Added 1.94%	52,486 $373,000
Q4 2017 Feb 02, 2018	SELL	$7.25 - $15.65 $11,353 - $24,507	-1,566 Reduced 2.95%	51,488 $499,000
Q3 2017 Nov 06, 2017	BUY	$12.0 - $15.0 $636,648 - $795,810	53,054	53,054 $737,000

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.44B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account